Code | 5271E | ||||||||||
MA number | 59/0007/24-S | ||||||||||
Product Form: | cps end 14x1x120 mg (blis.OPA/Al/PVC//Al - jednotk.bal.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Zentiva, k.s., Czechia | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 31.01.2024 |
Validity: | 31.01.2029 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Jaxteran 120 mg_240 mg_03.2024.pdf |
PIL: | PIL_Jaxteran 120 mg_240 mg_03.2024.pdf |
Safety feature | Yes |
Data update: | 06.02.2024 |